Did you know that every 33 seconds, one person in the United States dies from cardiovascular disease? This alarming statistic highlights just how widespread and serious heart disease is. Despite its prevalence, heart disease remains a condition without a definitive cure. The best way to manage it effectively is through a combination of prescribed medications and consistent lifestyle modifications such as diet, exercise, and stress management.
Given the persistent threat of cardiovascular disease, staying informed about advancements in cardiology innovation is crucial for anyone looking to protect their heart health. These innovations not only improve how we manage existing heart conditions but also pave the way for earlier detection and more personalized treatment plans.
Keeping up with the latest trends and breakthroughs in cardiovascular health and medicine empowers patients and healthcare providers alike to implement the most effective strategies for preventing heart-related complications. In this article, we will explore five of the most promising and impactful cardiology innovations currently shaping the future of heart care.
If you want to take control of your cardiovascular health and benefit from cutting-edge treatments, consult with the best cardiologists in Brooklyn who specialize in these advanced approaches and are committed to delivering personalized care tailored to your unique needs.
5 Latest Cardiology Innovations to Watch Out
Here are the latest trends that you should look out for in cardiovascular health and medicine, including:
- Diabetes medications offer cardiovascular benefits:
According to the American Heart Association (AHA), glucose-lowering drugs are not only a game changer for people with type 2 diabetes but also lower their cardiovascular risks and improve their heart health.
Research now suggests that these drugs may also improve heart health in people with obesity, who aren’t diagnosed with diabetes. One trial of semaglutide (a medicine used to treat type 2 diabetes and obesity), shows promising results in lowering the risk of heart problems in people with diabetes and is approved for long-term weight management.
People with heart failure due to preserved ejection fraction (when your heart muscle becomes thick and stiff and not able to pump out enough blood to meet the body’s needs) and obesity get far better with this drug than going on a placebo. Semaglutide can lower heart-failure-related symptoms and improve the ability to exercise, resulting in greater weight loss. In one trial, researchers checked whether Semaglutide benefited people who were living with weight issues (but didn’t have diabetes but had cardiovascular disease). The findings show that the drug was superior to placebo in lowering cardiovascular-related death, nonfatal heart attacks, and nonfatal strokes.
Additionally, research on other diabetes medications like dual-acting GIP and GLP-1 agonists of the brand name Mounjaro, which was recently approved for weight loss and obesity treatment under the name of Zepbound shows a favorable effect on cardiovascular outcomes in people who are treated for obesity.
Research shows a 20% reduction in body weight in overweight people and a lower risk of cardiovascular death, stroke, myocardial infarction, or heart attack.
- Thrombectomy may provide more independence to severe stroke patients:
Research on endovascular thrombectomy, a minimally invasive surgical procedure used to remove a stroke-causing blood clot from an artery in the brain, covers one of 2023’s big stories. It can restore blood flow and prevent further brain damage and disability. This is the standard form of treatment for either small or medium-sized strokes.
While now it wasn’t clear if endovascular thrombectomy would benefit people with larger, more severe strokes, which account for ¼ of all strokes. However, in a study of people with severe strokes from China and other trials of people in North America, Europe, Australia, and New Zealand, researchers found endovascular thrombectomy within 24 hours of a stroke will produce superior results to standard medical care. This research shows that the individuals who received this treatment showed fewer signs of disabilities and were more functionally independent during the 3 months after treatment. It also pointed out that the third study of those treated for severe stroke in Europe and Canada showed similar outcomes.
Those who underwent endovascular thrombectomy become more functionally independent than those who had standard medical treatment alone. This study shows that thrombectomy patients were less likely to die.
- Injectable medications are making some treatments faster and easier:
Traditionally, you had to take daily pills or injectables every two weeks. However, today, there are newer and better options available now. Data shows people with injectable treatment can take it every 6 months. Now there are even longer gaps because the whole idea is one-and-done, it’s something people find easier for them. But the problem is, these things are not cheap. This finding led to the drug Zilebesiran, which showed the potential to lower pressure with an injection every 6 months at the American Heart Association’s Scientific Sessions 2023. These types of injectables make it easier for people to get the medication they need. But the main problem remains, it’s not cheap.
- A new drug to suppress the protein required for the development of hypertension:
Hypertension is one of the most common factors that lead to heart attacks, strokes, and other serious health problems. And half of all U.S. adults have hypertension. Also, it can lower your life expectancy by up to 5 years.
It keeps your blood pressure high and despite advancements in medications, fewer than 25% of those are being treated properly to manage their blood pressure. The numbers are getting worse as the mortality rate (due to high blood pressure) has risen more than 30% since the 1990s. Researchers are looking for innovative approaches and finding one strategy to thwart the development of hypertension by interfering with the mechanisms that produce it.
Angiotensinogen, a protein secreted by the liver, may play a key role in increasing blood pressure. Before that, research shows the more angiotensinogen produced the higher blood pressure management. Zilebesiran is an investigational drug that decreases the production of angiotensinogen.
Not only the suppression of angiotensinogen is more effective in reducing hypertension for longer periods. After injection, there is a possibility that it might be therapeutic for kidney and heart disease. The results are also highly significant because only a single dose is required to improve access to care and adherence to long-term drug regimens.
- New heart disease research and potential innovations in 2024:
There are 3 new cited innovations in gene editing in 2024, including:
- Research in New Zealand on gene editing technology shows that it can lower low-density lipoprotein (LDL). A small proof of principle study shows the first 10 patients have durable LDL reduction. Out of the 10 patients, 2 had very serious adverse events, – one died, and one had a heart attack, so the question of safety still exists.
- FDA approved a cure for sickle cell disease that harnessed the same CRISPR gene-editing technology. This approval is a breakthrough because it’s the first medicine to receive U.S. approval. The drugs in development are used for treating lipoprotein, as a development to keep front and center for the coming year. If it works, a 20% reduction is noted in heart disease risk factors in the population that has never been treated.
- FDA Modernization Act 2.0 has been released, which opens the door for moving beyond mandatory animal testing toward the new era of using stem cells, organoids, artificial intelligence, machine learning, and computer models for drug discovery.
As heart disease becomes more common each year. Navigating through these innovations in cardiovascular health is extremely useful to keep your heart healthy and prevent heart-related problems and conditions.
If you suffer from heart problems or need advice on how to keep your heart healthy, visit our cardiology clinic in Brownville for professional medical help. Call us on +1(347) 384-5690. The Cardiologists at Doral Health & Wellness consistently have outstanding patient satisfaction ratings. The professionals at Heart Specialist Brooklyn are able to greatly improve their patient’s health and quality of life because of their vast training and experience. New Yorkers can get the greatest medical, surgical, and cardiovascular care at Doral Health & Wellness Brooklyn. Visit us at 1797 Pitkin Avenue, Brooklyn, NY 11212.
